编者按：2020年ASCO会议已落下帷幕，但追寻更好的治疗策略的脚步却从未停止。我国胃癌年新发病例约50万，占全球新发病例的一半，是名副其实的胃癌大国。随着近年精准治疗的发展，胃癌的HER2检测和围术期抗HER2治疗不断开拓。今年ASCO会...
导读：对于70岁以上的低危早期乳腺癌患者来说，保乳术后是否要进行放疗或内分泌治疗？近期《Breast Cancer Research and Treatment》上发表了一篇题目为《Radiation and/or endocrine th...
编者按：随着全球生物制剂市场份额的增加及各种生物制剂专利逐渐到期，生物类似药蜂拥而至。但国内的生物类似药较少，尚处于早期阶段。基于此现状，我们不禁要画个问号，生物类似药能在治疗效果和安全性上与原研药保持一致吗？国内的专家在临床应用上应该注意...
In this interview， Dr. Peng Ling from the First Affiliated Hospital，School of Medicine， Zhejiang University， Dr. Mei Hen...
In this interview， Professor Xu Yingying from the First Affiliated Hospital of China Medical University will talk with P...
Editor’s note: The annual meeting of American Society of Clinical Oncology (ASCO) was held in the form of online confer...
At the 2020 ASCO conference， Professor Thomas Powles from Barts Cancer Institute and the London School of Medicine and D...
Editor’s note: May 29th， 2020 to 2nd June 2020， the annual meeting of the American Society of Clinical Oncology (ASCO) ...
The Annual Meeting of American Society of Clinical Oncology (ASCO) this year was held on-line during 29/5 to 2/6. In the...
编者按：2020年ASCO年会已在线上成功举办，在这场国际肿瘤学的奥斯卡盛典上，乳腺癌领域唯一一项入选LBA（Late-Breaking Abstract）的 ECOG-ACRIN 2108研究引起了专家学者的广泛讨论。日前，《肿瘤瞭望》邀...
专业肿瘤医学资讯与学术服务平台